These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 28796375)

  • 21. Knockdown of long noncoding RNA SPRY4-IT1 suppresses glioma cell proliferation, metastasis and epithelial-mesenchymal transition.
    Liu H; Lv Z; Guo E
    Int J Clin Exp Pathol; 2015; 8(8):9140-6. PubMed ID: 26464658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long non-coding RNA SPRY4-IT1 pormotes colorectal cancer metastasis by regulate epithelial-mesenchymal transition.
    Shen F; Cai WS; Feng Z; Chen JW; Feng JH; Liu QC; Fang YP; Li KP; Xiao HQ; Cao J; Xu B
    Oncotarget; 2017 Feb; 8(9):14479-14486. PubMed ID: 27391336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long non-coding RNA SPRY4-IT1 promotes proliferation and metastasis in nasopharyngeal carcinoma cell.
    Li Y; Liao Z; Wang R; Liang Z; Lin Z; Deng S; Chen L; Liu Z; Feng S
    PeerJ; 2022; 10():e13221. PubMed ID: 35378932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long non-coding RNA SPRY4-IT1 promotes development of hepatic cellular carcinoma by interacting with ERRĪ± and predicts poor prognosis.
    Yu G; Lin J; Liu C; Hou K; Liang M; Shi B
    Sci Rep; 2017 Dec; 7(1):17176. PubMed ID: 29214989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long Non-Coding RNA SPRY4-IT1 Reverses Cisplatin Resistance by Downregulating MPZL-1 via Suppressing EMT in NSCLC.
    Ye Y; Gu J; Liu P; Wang H; Jiang L; Lei T; Yu S; Han G; Wang Z
    Onco Targets Ther; 2020; 13():2783-2793. PubMed ID: 32308413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long noncoding RNA SPRY4-IT1 is upregulated in esophageal squamous cell carcinoma and associated with poor prognosis.
    Xie HW; Wu QQ; Zhu B; Chen FJ; Ji L; Li SQ; Wang CM; Tong YS; Tuo L; Wu M; Liu ZH; Lv J; Shi WH; Cao XF
    Tumour Biol; 2014 Aug; 35(8):7743-54. PubMed ID: 24810925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long noncoding RNA SPRY4-IT1 predicts poor patient prognosis and promotes tumorigenesis in gastric cancer.
    Peng W; Wu G; Fan H; Wu J; Feng J
    Tumour Biol; 2015 Sep; 36(9):6751-8. PubMed ID: 25835973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long intergenic non-coding RNA 00152 promotes lung adenocarcinoma proliferation via interacting with EZH2 and repressing IL24 expression.
    Chen QN; Chen X; Chen ZY; Nie FQ; Wei CC; Ma HW; Wan L; Yan S; Ren SN; Wang ZX
    Mol Cancer; 2017 Jan; 16(1):17. PubMed ID: 28109288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
    Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
    World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiRNA-26a Contributes to the Acquisition of Malignant Behaviors of Doctaxel-Resistant Lung Adenocarcinoma Cells through Targeting EZH2.
    Chen J; Xu Y; Tao L; Pan Y; Zhang K; Wang R; Chen LB; Chu X
    Cell Physiol Biochem; 2017; 41(2):583-597. PubMed ID: 28214878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long non-coding RNA SPRY4-IT1 promotes cell proliferation and invasion by regulation of Cdc20 in pancreatic cancer cells.
    Guo W; Zhong K; Wei H; Nie C; Yuan Z
    PLoS One; 2018; 13(2):e0193483. PubMed ID: 29489909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LncRNA HOXA-AS2 Promotes Oral Squamous Cell Proliferation, Migration, and Invasion via Upregulating EZH2 as an Oncogene.
    Zhao Z; Xing Y; Yang F; Zhao Z; Shen Y; Song J; Jing S
    Technol Cancer Res Treat; 2021; 20():15330338211039109. PubMed ID: 34519570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long Noncoding RNA CPS1-IT1 Suppresses Cell Proliferation and Metastasis in Human Lung Cancer.
    Xiaoguang Z; Meirong L; Jingjing Z; Ruishen Z; Qing Z; Xiaofeng T
    Oncol Res; 2017 Mar; 25(3):373-380. PubMed ID: 27662619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Upregulation of long noncoding RNA SPRY4-IT1 modulates proliferation, migration, apoptosis, and network formation in trophoblast cells HTR-8SV/neo.
    Zou Y; Jiang Z; Yu X; Sun M; Zhang Y; Zuo Q; Zhou J; Yang N; Han P; Ge Z; De W; Sun L
    PLoS One; 2013; 8(11):e79598. PubMed ID: 24223182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LncRNA MALAT1 promotes epithelial-to-mesenchymal transition of esophageal cancer through Ezh2-Notch1 signaling pathway.
    Chen M; Xia Z; Chen C; Hu W; Yuan Y
    Anticancer Drugs; 2018 Sep; 29(8):767-773. PubMed ID: 29916899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased expression of SPRY4-IT1 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer.
    Zhao XL; Zhao ZH; Xu WC; Hou JQ; Du XY
    Int J Clin Exp Pathol; 2015; 8(2):1954-60. PubMed ID: 25973088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Lnc RNA SPRY4-IT1 Modulates Trophoblast Cell Invasion and Migration by Affecting the Epithelial-Mesenchymal Transition.
    Zuo Q; Huang S; Zou Y; Xu Y; Jiang Z; Zou S; Xu H; Sun L
    Sci Rep; 2016 Nov; 6():37183. PubMed ID: 27853262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long non-coding RNA LOC554202 modulates chordoma cell proliferation and invasion by recruiting EZH2 and regulating miR-31 expression.
    Ma X; Qi S; Duan Z; Liao H; Yang B; Wang W; Tan J; Li Q; Xia X
    Cell Prolif; 2017 Dec; 50(6):. PubMed ID: 28963737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Upregulated long non-coding RNA SPRY4-IT1 predicts dismal prognosis for pancreatic ductal adenocarcinoma and regulates cell proliferation and apoptosis.
    Yao Y; Gao P; Chen L; Wang W; Zhang J; Li Q; Xu Y
    Gene; 2018 Jun; 659():52-58. PubMed ID: 29551494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LncRNA MSTO2P promotes proliferation and autophagy of lung cancer cells by up-regulating EZH2 expression.
    Wang LJ; Sun GZ; Chen YF
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3375-3382. PubMed ID: 31081092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.